News – Page 1108 – Endpoints News

So what’s star Broad investigator Feng Zhang up to now?

8 years ago

Bristol-Myers vet Douglas Manion bids Big Pharma farewell, takes the helm at Yale spinout Kleo

8 years ago

Merck cautiously steps into the PD-(L)1/CTLA-4 checkpoint fray. But should it ‘go big or go home’ instead?

8 years ago

Lexicon 3-for-3 in PhIII for a new diabetes pill, racking up a clean sweep under $1.7B Sanofi pact

8 years ago

Analysts project a big spike in COPD market as new drugs arrive; Valeant raises $930M in latest asset sale

8 years ago

New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing

8 years ago

Hunting new deals, Eli Lilly buddies up on diabetes R&D with $55M pact

8 years ago

Genentech axes its $1B-plus IDO drug deal with NewLink in the wake of underwhelming data

8 years ago

Actelion’s R&D group slammed with a setback as execs finalize $30B J&J deal

8 years ago

J&J woos Merck's Mathai Mammen to helm of pharma R&D, Hait takes over on external innovation

8 years ago

Novartis posts landmark CAR-T data as head-to-head rivalry with Kite Pharma looms

8 years ago

AstraZeneca raises $200M from its latest asset sale; Austin-based Lung Therapeutics raises $14M in venture cash

8 years ago

Teva turns the last corner in the CGRP migraine drug race with its 2nd round of promising PhIII data

8 years ago

AbbVie gets a big boost in the major league rheumatoid arthritis finals with promising PhIII data

8 years ago

President Trump asks Francis Collins to stay on at the NIH, sparking bipartisan applause

8 years ago

Kelly Martin once again finds himself at the helm of a biotech, sailing in choppy seas

8 years ago

Ramaswamy notches his 5th biotech startup in 3 years after inking a deal with Merck for PhIII urology drug

8 years ago

WuXi Biologics IPO reaps $509M windfall; Intellia strikes CRISPR pact with San Raffaele

8 years ago

July 12 FDA panel review looms as a watershed moment in Novartis’ campaign to win an historic new drug OK

8 years ago

ASCO17: Chi-Med spotlights positive colon cancer data as partner Eli Lilly preps landmark China rollout

8 years ago

AMRI fetches $922M in the latest CRO private equity buyout

8 years ago

ASCO17: AstraZeneca pumps up expectations on near-term cancer drug wins, looking to shed a rep for failure

8 years ago

PhIII details boost Acorda as execs rush to FDA with the clock ticking on a time bomb

8 years ago

Christoph Westphal finds the exit at his latest biotech creation — after the stock cratered

8 years ago

First page Previous page 1105 1106 110711081109 1110 1111 Next page Last page